Sponsor:
C. Babis Andreadis
Code:
NCT04545762
Conditions
Refractory Non-Hodgkin Lymphoma
Burkitt Lymphoma
Mantle Cell Lymphoma
Follicular Lymphoma
Lymphoplasmacytic Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Fludarabine
Cyclophosphamide
anti-CD19 CAR-T cells
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by C. Babis Andreadis on 2025-02-06.